Does novel fMRI working memory paradigm accurately detect cognitive impairment in multiple sclerosis?
I/DMT-based BOLD activation detects CI in MS. Larger studies are needed to confirm these findings.
The increased immunogenicity of replicon-based DNA vaccines allows for application of extremely low doses, thereby eliminating the concerns associated with conventional DNA vaccines, which have to be administered at milligram amounts to induce immune reactions in human subjects.